UK Biobank – the multi-million pound visionary medical project aimed at improving the prevention, diagnosis and treatment of a wide range of diseases that kill, disable or cause widespread misery (such as cancer, heart disease, diabetes, dementia, mental illness, joint disease and many other debilitating conditions) – announced today (Tuesday 22 August) that it has received the go-ahead to roll out its programme nationwide.
Following a three-month piloting phase in the Manchester area, the final protocol received unanimous backing from a team of international scientific and medical experts, and from the project’s funders.
The success of the 3,800-participant piloting phase means that, around the end of this year, letters will start going out to men and women aged 40 to 69, who will be invited to attend one of a network of assessment centres to be set up in locations all around the UK. The aim is to recruit half a million people – nearly one percent of the British population – over the next four years.
UK Biobank will gather, store and protect a vast bank of medical data and material that will allow researchers to study in depth, in decades to come, how the complex interplay of genes, lifestyle and environment affects our risk of disease. It is the first time that such a project has been attempted in such fine detail on such a vast scale.
The final protocol for the £61m project, which is being funded by the Medical Research Council (MRC), the Wellcome Trust, the Department of Health, the Scottish Executive and the North West Regional Development Agency has been subjected to rigorous and detailed scrutiny by an independent International Review Panel set up by the funders.
In its report, the panel concluded that: “UK Biobank has the potential, in ways that are not currently available elsewhere, to support a wide range of research, particularly investigations into complex interactions of various exposures, including genetic and lifestyle factors in the pathways to disease and health.” The panel were impressed with the level of detailed planning and piloting that had gone into the development of the protocol, and considered it to be one of the most fully developed protocols they had seen. UK Biobank was also found to have set new standards for automated blood sample processing and storage, supplemented by a sophisticated computerised system to track samples. The panel said the approach to ethical oversight and governance of the resource was “exemplary and would be held up as a gold standard across the world”.
The panel’s overall view was that “UK Biobank is a unique opportunity to build an amazingly rich resource with a range of endpoints for future research that justified the initial establishment costs.”
Professor Rory Collins, UK Biobank’s Principal Investigator said: “Clearly, everyone at UK Biobank is delighted with the support and enthusiasm that this unique public health project has received from the funders and, in particular, from the eminent independent experts who scrutinised every detail of our protocol and plans. We are also grateful for their ideas for adding value to the resource, which we are already starting to implement and will be exploring further with the many scientists already involved in UK Biobank, as well as with other international experts. In addition, we have established an independent International Scientific Advisory Board to help us develop the resource during the years to come. We will constantly review everything we do so as to maximise recruitment of the widest possible cross-section of the population, to improve the quality of the health-related information that is obtained, to inform participants and the public about our progress, and to uphold the highest scientific and ethical standards throughout. For decades to come, the UK Biobank resource should provide researchers around the world with vital insights into some of the most distressing diseases of middle and old age.”
The chairman of the International Review Panel, Professor Thorkild Sørensen, from the Institute of Preventive Medicine in Copenhagen, Denmark, said: “It was a great honour to chair the panel for this exciting and very important project. Comprehensive and impressive plans, based on valuable pilot studies, were presented to the panel, who unanimously endorsed the protocol and put forward a number of suggestions that would enhance the long-term value of this unique project.”
Dr Adrian Mercer, Chief Executive of South Manchester NHS Primary Care Trust – the first PCT to participate in the piloting phase – said: “The project was successfully launched in Manchester, being well received by those invited to take part and supported by PCTs and clinicians. I am sure the roll-out nationally will be equally successful.”
Professor Colin Blakemore, Chief Executive of the Medical Research Council said: “UK Biobank offers enormous potential to find out more about the complex links between our genes, the lives we lead and our health. The Medical Research Council is delighted to continue to fund this project, which will provide scientists with extraordinary information and will offer unprecedented opportunities to improve people’s lives. The project, under the leadership of Rory Collins, is already helping researchers by pioneering new ways to gather and collate large quantities of information. Over the coming years the data from this study will grow into a unique resource for future generations.”
Dr. Mark Walport, Director of the Wellcome Trust said: “The piloting of UK Biobank has gone extremely well. The funders, advised by international peer reviewers, were very impressed by the leadership of Rory Collins and his team and by their plans for the future implementation of UK Biobank. I am delighted that we have agreed full funding for the programme and that large-scale recruitment will start shortly. UK Biobank, already watched with envy by researchers across the world, will provide a remarkable resource, allowing us to answer important questions about health and disease. This study has the opportunity to make a real difference to the health of future generations.”
Margaret Willson | alfa
Make way for the mini flying machines
21.03.2018 | American Chemical Society
New 4-D printer could reshape the world we live in
21.03.2018 | American Chemical Society
In just a few weeks from now, the Chinese space station Tiangong-1 will re-enter the Earth's atmosphere where it will to a large extent burn up. It is possible that some debris will reach the Earth's surface. Tiangong-1 is orbiting the Earth uncontrolled at a speed of approx. 29,000 km/h.Currently the prognosis relating to the time of impact currently lies within a window of several days. The scientists at Fraunhofer FHR have already been monitoring Tiangong-1 for a number of weeks with their TIRA system, one of the most powerful space observation radars in the world, with a view to supporting the German Space Situational Awareness Center and the ESA with their re-entry forecasts.
Following the loss of radio contact with Tiangong-1 in 2016 and due to the low orbital height, it is now inevitable that the Chinese space station will...
Fraunhofer Institute for Organic Electronics, Electron Beam and Plasma Technology FEP, provider of research and development services for OLED lighting solutions, announces the founding of the “OLED Licht Forum” and presents latest OLED design and lighting solutions during light+building, from March 18th – 23rd, 2018 in Frankfurt a.M./Germany, at booth no. F91 in Hall 4.0.
They are united in their passion for OLED (organic light emitting diodes) lighting with all of its unique facets and application possibilities. Thus experts in...
A new scenario seeking to explain how Mars' putative oceans came and went over the last 4 billion years implies that the oceans formed several hundred million...
For the first time, an interdisciplinary team from the University of Basel has succeeded in integrating artificial organelles into the cells of live zebrafish embryos. This innovative approach using artificial organelles as cellular implants offers new potential in treating a range of diseases, as the authors report in an article published in Nature Communications.
In the cells of higher organisms, organelles such as the nucleus or mitochondria perform a range of complex functions necessary for life. In the networks of...
Animal photoreceptors capture light with photopigments. Researchers from the University of Göttingen have now discovered that these photopigments fulfill an...
19.03.2018 | Event News
16.03.2018 | Event News
13.03.2018 | Event News
21.03.2018 | Physics and Astronomy
21.03.2018 | Materials Sciences
21.03.2018 | Life Sciences